Navigation Links
DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Date:5/28/2013

VANCOUVER, British Columbia and MENLO PARK, Calif., May 28, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the company would present an abstract entitled "Phase I/II Study of VAL-083 (dianhydrogalactitol) in Patients with Recurrent Malignant Glioma or Progressive Secondary Brain Tumor" at the American Society of Clinical Oncology (ASCO) Annual Meeting, which is being held May 31 – June 4, 2013 in Chicago, Illinois, USA.

DelMar will present new clinical data from its ongoing brain cancer clinical trial with VAL-083 during the Central Nervous System Tumor Session on Saturday June 1, from 8:00 to 11:45 AM.  The Company's permanent ASCO abstract (#2093) can be viewed by clicking here or searching http://abstracts2.asco.org/

For further details on DelMar's clinical trial please visit: http://www.clinicaltrials.gov/ct2/show/NCT01478178?term=VAL--083&rank=1

About DelMar Pharma
Del Mar Pharmaceuticals was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The Company's lead asset, VAL-083, is currently undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.  VAL-083 benefits from extensive clinical research sponsored by the US National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia (CML) and lung cancer in China. P
'/>"/>

SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
10. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
11. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Ala. , Aug. 27, 2015 /PRNewswire/ ... Outpatient Pharmacy Provider (IOPP™) is expanding its ... of a medication-focused transition of care program ... named "RxCare Management," provides hospitals with technology ... hospital performance measures that have been mandated ...
(Date:8/27/2015)... , Aug. 27, 2015  A mere one ... Booz Allen Hamilton . A new white ... development inefficiencies are impeding and disrupting manufacturers, success. ... Waste and Improve Value In Product Development Processes ... inaccessible data and how it affects the product development ...
(Date:8/27/2015)... NorthStar Anesthesia , one of the country,s ... selected by Mercy, based in Toledo, Ohio ... hospitals:  Mercy St. Vincent  Medical Center and Mercy St. ... St. Charles  Hospital in Oregon and ... "As we looked to create a more ...
Breaking Medicine Technology:Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2New White Paper Reveals How Manufacturers Can Improve Product Development Processes 2Four Mercy Hospitals in Northwest Ohio Select NorthStar Anesthesia 2
... Medical Inc. (OTC Bulletin Board: PUMD ), ... signing of an agreement for $3.125 million in equity ...  The proceeds of the financing will be used to ... activities associated with final preparation, manufacturing and eventual marketing ...
... ... if (typeof(lpUnit)==,undefined,) var ... var shortURL = ""; BitlyCB.alertResponse = function(data) ... grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var ...
Cached Medicine Technology:UPDATE - ProUroCare Announces $3 Million Financing Agreement 2UPDATE - ProUroCare Announces $3 Million Financing Agreement 3Transcept Pharmaceuticals to Present at BIO Investor Forum 2Transcept Pharmaceuticals to Present at BIO Investor Forum 3Transcept Pharmaceuticals to Present at BIO Investor Forum 4Transcept Pharmaceuticals to Present at BIO Investor Forum 5Transcept Pharmaceuticals to Present at BIO Investor Forum 6Transcept Pharmaceuticals to Present at BIO Investor Forum 7
(Date:8/27/2015)... ... August 27, 2015 , ... ... and leading biopharmaceutical contract development manufacturing company (CDMO), announced today that it has ... for $205.68M in cash. , The addition of Cytovance Biologics to ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... signed a partnership agreement for quality market research promotion on the Internet. ... Black Swan Analysis. , Commenting on the partnership agreement, Natalie Aster, Assistant ...
(Date:8/27/2015)... ... August 27, 2015 , ... Susan Harris and ... relieve vaginal discomfort due to pre- and post-menopause, chemotherapy, and child birth. , ... which delivers controlled energy to the vaginal tissue, revitalizing cells so they make more ...
(Date:8/27/2015)... ... August 27, 2015 , ... Sunbelt® Bakery, maker of delicious ... syrup, is changing the expectation of how protein bars should taste with the launch ... any other protein bar on the market today. , The new Protein Delights ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... NetDimensions ... , “The companies selected have the platforms required not only to effectively deliver, curate ... Taylor, President of Training Industry, Inc. , For six consecutive years, NetDimensions has ...
Breaking Medicine News(10 mins):Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 4Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 3Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 2Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 3Health News:Sunbelt® Bakery Changes the Expectations of How Protein Bars Should Taste with the Introduction of Its New Protein Delights 2Health News:Sunbelt® Bakery Changes the Expectations of How Protein Bars Should Taste with the Introduction of Its New Protein Delights 3Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 2Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 3
... 17 Carla Bluhm, a developmental psychologist and visiting assistant ... class of 2007, have recently completed a book on the ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080220/DC14623 ) , ... Identity and the New Science of Face Transplants" begins with ...
... for Physicians , , VOORHEES, ... infection (CDI) in geriatric and pediatric populations ... in CDI incidence in many age groups, healthcare professionals need ... patient populations. , , To ...
... Dec. 17 minSURG Corporation, along with,its ... NuFix,Inc. ("NuFix"), along with its affiliate Nutech ... settlement of the lawsuits styled Orthopedic,Development Corporation ... Inc., Kenneth Horton and Todd Gilbert, Case ...
... 17 Michelle Aguilar may be the latest,"Biggest Loser" but she ... that when working out hard, it,s important to include the nutrients ... a day provide.,Aguilar is the latest person to lend her upper ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081217/AQW560 ) , ...
... Labs announces the,availability of its advanced ocular nutrition line ... CVS Pharmacy stores ( www.cvs.com ),nationwide. , ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081217/CLW029-b ... marks the first time EyeScience Macular Health Formula(TM) and,EyeScience ...
... improve cognitive impairment, study says , , WEDNESDAY, Dec. ... Alzheimer,s patients, cognitive symptoms are also a safe ... such as aggression, wandering and paranoia, according to ... that examined the effectiveness of three popular cholinesterase ...
Cached Medicine News:Health News:Psychology of Face Transplants is Subject of New Book by Allegheny College Professor 2Health News:Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients 2Health News:EyeScience's New Ocular Nutrition Supplements Available at CVS Stores 2Health News:Alzheimer's Drugs Also Treat Behavioral, Psych Problems 2
... Precision Dynamics Corporation offers a ... serving infants to adults. Armboard ... non-woven material assuring easy cleaning ... cross contamination. Choose from three ...
The Side Rail Socket fits all American-made tables with standard side rails. Fits accessories with flat mounting posts up to 1/4"W x 1"L. Attaches at rail ends or notches....
Stainless steel construction to withstand sterilization modalities (EtO, Steris®, and Sterrad®) Wide angle of view...
Stainless steel construction to withstand sterilization modalities (autoclave, EtO, Steris®, and Sterrad®) Fully autoclavable, with both distal and proximal ends uniquely soldered for longe...
Medicine Products: